Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In the industrial world you wouldn't start a full scale production operation without pre-sold orders. Or making prototypes that haven't been tested by a company interested in making a purchase. Research alone on the products would take several years to complete. It sounds like this company is taking the right steps to develop a product within specific guidelines. I see a positive outlook. Have a great day!
Very sincere statements.
Why don't you check for me?
Go to pumpsanddumps.com there is nothing on that site about BIEL.
The conference call news is great! This is very positive for the company. I see that they have other avenues lined up. This should push the price per share up.
Love it! Fact 9 is great.
Lets stick to the facts. This company has products that are selling. The FDA news alone will push the price upLets Go Over Facts
Fact 1- We Have Product
Fact 2- We Have Distribution
Fact 3- We Have Product In Stores
Fact 4- We Have Sold Product
Fact 5- We Have FDA Reviewing Product for reclassification.
Fact 6- We Have A Company That Supports Their Products And Wants Them To Succeed.
Fact 7- We Have A Company Doing The Right Things To Advance the Company.
Fact 8- We Have A Product That Can Heal Without Drugs. THIS IS HUGE!!!!!!!!!!!!!!!!!!!
This stock is lighting up. A lot of stock boards are talking about it. Huge interest! It's on the radar by many. Have a great day everyone.
A lot of loading the past week. It sounds like we might be getting some good news soon.
Lets go BIEL!
BIEL has always been a keeper stock.
Next Company Update: Thursday, June 4, 2015
Healing the world one patch at a time.
Everything Positive On This Board. Let's go BIEL!
FDA news will send this to penny land.
Great Products! Let's Go BIEL!
Lets Go Over Facts
Fact 1- We Have Product
Fact 2- We Have Distribution
Fact 3- We Have Product In Stores
Fact 4- We Have Sold Product
Fact 5- We Have FDA Reviewing Product for reclassification.
Fact 6- We Have A Company That Supports Their Products And Wants Them To Succeed.
Fact 7- We Have A Company Doing The Right Things To Advance the Company.
Fact 8- We Have A Product That Can Heal Without Drugs. THIS IS HUGE!!!!!!!!!!!!!!!!!!!
BIEL is a great ground floor opportunity. What other penny stock has products to sell and distribute? What other penny stocks have products in stores? There are not many at this price point. The company provides updates and information about moving forward never behind. This is great opportunity and people know it. That's why it is trading million of shares a day. This is my opinion. Have a great day everyone!
I finally had a chance to listen to the radio interview. I'd say I'm very happy with the way it was presented. I still think there is ground to be covered but it looks like Biel is in position to hit a Homerun. Pain management with no drugs. This is huge! I can't wait to see what the future holds. Have a great day everyone!
One tick up. .0005
Store Count by State for Walgreens.
Total Drugstores - 8,232
Through February 28, 2015
Equals Huge Sales with FDA approval.
The future of BIEL looks Good to me!
LOVE IT. LET THE GOOD TIMES ROLL. LETS GO BIEL,
DDLS Your point holds no value if you haven't tried the product. The fact is that it is being sold.
Seven great posts about BIEL! I really like the positive position the company is taking with distribution. Let's go BIEL!
Have you tried the product?
I'm looking forward to positive gains. BIEL does a great job keeping its investors updated. Have a great day!
New distribution companies are being added frequently. This stock will be soaring soon.
This is great news! Let's go Biel!
It's been sometime since I last posted. I'm anticipating good news soon.
Please do not address me as Dude. Braun is a well known highly rated distributor of medical devices. I suggest doing some research on a company so you have some input that is worth talking about. Have a great day.
Askjsell obviously you have no experience with distribution companies. World class distribution companies would never take on a product they couldn't sell. Small distributors would. This is a large company and wouldn't want to be part of a product that would fail. The name alone is huge. B.Braun + Biel = Success. Have a great day.
Biel+ B.Braun = Success
Smart move with B.Braun. This was very well thought out. Let's go Biel!
B.Braun is a big time company. This news is fantastic and will definitely bring more players to the table. Get on board! The train is leaving the station. Lets go BIEL!
I agree with Seven-up. It is a matter of time before take off. Have a great day everyone.
ddls one fact remains the same is that this company has a product and is selling it everyday. Everyone can agree that FDA news will send this stock up. Have a great day.
Remember this article from GSK. It is time to move into The Bioelectronics field.
Exploratory funding programme
Bioelectronics Innovation Challenge
The functions and organ systems of our body are, to a significant extent, controlled by electrical signals that travel along the nerves. Bioelectronic medicines will aim to control biological processes and treat disease by modulating these electrical impulses.
They will be minaturised devices that connect to specific groups of neurons or their nerve fibres and modulate the electrical signalling patterns, to restore the healthy states of targeted organs and functions.
We believe bioelectronic medicines could allow us to address some diseases that have so far been untreatable, and others with greater precision and fewer side effects than with conventional molecular medicines.
Funding research into bioelectronics
As a sign of our commitment to this new field of research, we have put in place multiple mechanisms to activate and integrate the research community around the fundamental challenges of developing these new treatments.
For example, through our exploratory funding programme, we are currently funding 33 research projects across more than 25 institutions, which will begin to detail how nerves in the body are related to particular diseases. This will allow us to start to understand the firing patterns of those nerves, and to begin to explore new technologies that will enable us to interface with these nerve fibres.
Through our $50m venture capital arm, Action Potential Venture Capital, we are investing in start-ups and technology platofrms that aim to advance the development of bioelectronic medicines.
We have also launched an exciting opportunity for external investigators to contribute to the development of a miniaturized, implantable, wireless, visceral nerve pre-clinical research platform. A $5m fund to back academics and companies seeking to solve this challenge is open for application for phase 1 funding during October-November 2014. In addition, the first team to demonstrate full functionality of their device according to specified criteria will be awarded a $1m prize.
You can find out more about the Bioelectronics R&D we are already doing in this commentary article (PDF) published in the scientific journal Nature.
Together with the emerging bioelectronics community we also recently published a roadmap which will enable this vision to become a reality.
FYI- BioElectronics Analyst Brief: Beyond the Traditional Therapies by Small Cap Traders
Share with LinkedIn
NEW YORK, Oct 20, 2014 /PRNewswire/ -- There can be no doubt that the market for pain relief products will continue to grow, regardless of the economic climate. As the massive baby boomer population ages their aches and pains will follow them and the affordable Care act should make more funding available to spend on pain relief products. As the population becomes more health aware, the use of oral pain medications like aspirin is being questioned and too often topical analgesics don't provide the desired effect. Electronic stimulation of inflamed tissue seems to be a viable alternative that has yet to be fully embraced in the medical community or the general population.
BioElectronics Corporation (OTCBB: BIEL), a development stage company, is engaged in the manufacturing of inexpensive, drug-free, anti-inflammatory medical devices and patches. Its Products include Testimonials, ActiPatch, Allay, Smart Insole and RecoveryRx. The underlying concept of the BIEL product line is to replace the short duration, high power treatments which can only be obtained in the clinic by a trained professional, with an easy to use, self-administered, very low power device that can be used 24 hours per day.
BIEL has good, effective products available, yet the marketplace is inundated with competing electronic pain relief products. The company is working to create brand awareness for their superior products, a process that takes time. Investors willing to take a chance on a development stage company in the burgeoning health care market should be looking at BioElectronics Corp.
An analyst brief which covers a brief technical analysis and analyst recommendation can be viewed in its entirety by using the link below. There is no cost obligation required to view this report:
Everyone is holding their shares and waiting for the news. Who would sell their shares at this time? Not me.
Let's go Biel! I'm thinking we are real close.